The biochip market in Thailand is expected to reach a projected revenue of US$ 425.0 million by 2033. A compound annual growth rate of 10.9% is expected of Thailand biochip market from 2026 to 2033.
The Thailand biochip market generated a revenue of USD 181.2 million in 2025 and is expected to reach USD 425.0 million by 2033.
The Thailand market is expected to grow at a CAGR of 10.9% from 2026 to 2033.
In terms of segment, dna chips was the largest revenue generating type in 2025.
Lab-on-chip is the most lucrative type segment registering the fastest growth during the forecast period.
Biochip market data book summary
Market revenue in 2025
USD 181.2 million
Market revenue in 2033
USD 425.0 million
Growth rate
10.9% (CAGR from 2026 to 2033)
Largest segment
Dna chips
Fastest growing segment
Lab-on-chip
Historical data
2021 - 2024
Base year
2025
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
DNA Chips, Lab-on-chip, Tissue Arrays, Protein Chips, Cell Arrays
Key market players worldwide
Agilent Technologies Inc, PerkinElmer, Illumina Inc, Bio-Rad Laboratories Inc, Standard BioTools Inc, GE HealthCare Technologies Inc Common Stock, Thermo Fisher Scientific Inc, Qiagen NV, Randox
Other key industry trends
In terms of revenue, Thailand accounted for 1.2% of the global biochip market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Asia Pacific, Japan biochip market is projected to lead the regional market in terms of revenue in 2033.
India is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,433.9 million by 2033.
Thailand has a rapidly aging population. As per the Economic Research Institute for ASEAN and East Asia (ERIA) in 2021, the country’s population is rapidly aging. According to the same report, Thailand has the world's third-fastest aging population.
The number of people aged 60 and above in the country accounts for 13 million, i.e., 20% of the population. As aging is a risk factor for cancer, cardiovascular diseases, diabetes, and others, it is contributing significantly to the country's disease burden.
Moreover, the country’s market is significantly driven by rising investments by leading biopharmaceutical companies in the country, the growing biotechnology sector, and supportive government legislation.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biochip Market will help companies and investors design strategic landscapes.
Dna Chips was the largest segment with a revenue share of 57.06% in 2025.
Horizon Databook has segmented the Thailand biochip market based on dna chips, lab-on-chip, tissue arrays, protein chips, cell arrays covering the revenue growth of each sub-segment from 2021 to 2033.
Thailand has a rapidly aging population. As per the Economic Research Institute for ASEAN and East Asia (ERIA) in 2021, the country’s population is rapidly aging. According to the same report, Thailand has the world's third-fastest aging population.
The number of people aged 60 and above in the country accounts for 13 million, i.e., 20% of the population. As aging is a risk factor for cancer, cardiovascular diseases, diabetes, and others, it is contributing significantly to the country's disease burden.
Moreover, the country’s market is significantly driven by rising investments by leading biopharmaceutical companies in the country, the growing biotechnology sector, and supportive government legislation.
Thailand Biochip Market Type Outlook (Revenue, USD Million , 2021-2033)
DNA Chips
Protein Chips
Lab-on-chip
Tissue Arrays
Cell Arrays
Thailand Biochip Market End Use Outlook (Revenue, USD Million , 2021-2033)
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostics Centers
Academic & Research Institutes
Others
Reasons to subscribe to biochips market databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of biochips market databook
Our clientele includes a mix of biochips market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Thailand biochips market, including forecasts for subscribers. This country databook contains high-level insights into Thailand biochips market from 2021 to 2033, including revenue numbers, major trends, and company profiles.